Advertisement

Topics

GeneOhm Sciences, Inc Company Profile

03:36 EDT 26th September 2018 | BioPortfolio

GeneOhm Sciences, Inc. is a molecular diagnostic company at the forefront of developing rapid, nucleic acid-based systems, to detect and identify infectious agents and genetic variations. Leveraging the advantages of rapid, molecular-based diagnostics, we aspire to transform health-care by enabling earlier and more definitive clinical decisions that improve both the quality and the cost of patient care. The company is dedicated to offering laboratories and clinicians state-of-the-art, FDA-cleared, molecular based tests that can provide results in less than two hours. Established in San Diego, California in 2001, the company merged with Infectio Diagnostic, (I.D.I.), Inc. of Québec, Canada in 2004. The integrated company combines an extensive portfolio of proprietary technology, know-how, and capabilities with an experienced and accomplished management team.
Our current commercial product portfolio includes two rapid, amplified nucleic acid-based assays cleared by the FDA, Health Canada and bearing the CE mark: the IDI-Strep B™ Assay for rapid detection of Group B Streptococcus and the IDI-MRSA™ Assay for detection of methicillin-resistant Staphylococcus aureus directly from clinical specimens. These breakthrough products are the first molecular-based diagnostic products cleared by the FDA which meet the specifications required to replace standard culture methods.

Location

6146 Nancy Ridge Drive
San Diego
California
92121
United States of America

Contact

Phone: (858) 334-6300
Fax: (858) 334-6301
Email: customerservice@geneohm.com


News Articles [567 Associated News Articles listed on BioPortfolio]

Almac Sciences: Company Activity and Sharing Risks in Collaborations

In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they ...

CV Sciences, Inc. Repays Remaining Debt

LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the pr...

Urovant Sciences files for Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. filed for an initial public offering on Nasdaq.

wikifolio whispers p.m. zu Gilead Sciences, Nemetschek, E.ON ...

Gilead Sciences 0.49% DerProfessor (POWREV01): Biotech schwächelt. In diesem Umfeld wird auch GILEAD auf längere Sicht nicht performen. (14.05. 12:11) >> mehr comments zu Gilead Sciences: www.boers....

German Academies of Sciences offer recommendations for the reform of doctoral practices

(Leopoldina) Institutional responsibility for the doctorate at universities must be strengthened. This is the recommendation offered in the statement 'Doctorate in Transition', now available in Englis...

Roivant Launches New China-Based Startup Sinovant Sciences

Fresh off its first Pipeline Day last week, Vivek Ramaswamy’s Roivant Sciences is taking aim at breaking into the Chinese market. Roivant has launched another company called Sinovant Sciences.

Roivant launches new startup Sinovant Sciences in China

Global healthcare company Roivant Sciences has launched a spin-off called Sinovant Sciences in Shanghai, China to primarily develop innovative therapeutics...Read More... The post Roivant launches new...

A bigger, better Office for Life Sciences

The Department for Business, Innovation and Skills (BIS) and the Department of Health (DH) are joining their life sciences functions to create a new, expanded Office for Life Sciences.BIS and DH have ...

Clinical Trials [190 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1062 Associated Companies listed on BioPortfolio]

GeneOhm Sciences

GeneOhm Sciences uses the flow of electric current through DNA to detect genetic mutations. This proprietary chip-based technology allows clinicians to identify a patient's mutations accurately, sensi...

GeneOhm Sciences, Inc.

GeneOhm Sciences, Inc. is a molecular diagnostic company at the forefront of developing rapid, nucleic acid-based systems, to detect and identify infectious agents and genetic variations. Leveraging t...

GeneOhm Sciences, Inc

GeneOhm Sciences, Inc. is a molecular diagnostic company at the forefront of developing rapid, nucleic acid-based systems, to detect and identify infectious agents and genetic variations. Leveraging t...

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

More Information about "GeneOhm Sciences, Inc" on BioPortfolio

We have published hundreds of GeneOhm Sciences, Inc news stories on BioPortfolio along with dozens of GeneOhm Sciences, Inc Clinical Trials and PubMed Articles about GeneOhm Sciences, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GeneOhm Sciences, Inc Companies in our database. You can also find out about relevant GeneOhm Sciences, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record